Cargando…
Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
Background: Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) constitute rare chronic inflammatory biliary diseases which likely comprise genetic, environmental and autoimmune factors. Specific inhibitory (auto-) antibodies against the muscarinic acetylcholine receptor type...
Autores principales: | Wilde, Anne-Christin Beatrice, Greverath, Lena Maria, Steinhagen, Lara Marleen, de Chamorro, Nina Wald, Leicht, Elise, Fischer, Janett, Herta, Toni, Berg, Thomas, Preuss, Beate, Klein, Reinhild, Tacke, Frank, Müller, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836427/ https://www.ncbi.nlm.nih.gov/pubmed/35160133 http://dx.doi.org/10.3390/jcm11030681 |
Ejemplares similares
-
Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes
por: Mayer, Christian, et al.
Publicado: (2020) -
Real-World Clinical Management of Patients with Primary Biliary Cholangitis—A Retrospective Multicenter Study from Germany
por: Wilde, Anne-Christin Beatrice, et al.
Publicado: (2021) -
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022) -
Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984) -
Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)